Back to search

Switzerland· 39081017

Proglicem, Kapseln

A diazoxide product containing diazoxidum, registered in Switzerland by MSD Merck Sharp & Dohme AG and dispensed under Swissmedic category B. The same ATC class is registered in 4 of our 19 countries.

Cat B (Swissmedic)ATC V03AH01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedProglicem, KapselnATCV03AH01REGISTER NO.39081017PACKS LISTED0CHECKEDSeptember 12, 2026

Where it is registered

Diazoxide is registered in 4 of 19 countries.

Countries holding a registration under ATC V03AH01 (diazoxide), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 2 of them publish a price we can compare per daily dose

Diazoxide · ATC V03AH01

4 / 19 countries

  • Canada
  • Netherlands
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
diazoxidum
Manufacturer
MSD Merck Sharp & Dohme AG
Country
Switzerland (CH)
ATC code
V03AH01
ATC class
Diazoxide
Swissmedic category
B
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

248 interactions on record for diazoxide.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Diazoxide · interactions on record

248 records

  • 1 severe
  • 243 moderate
  • 4 minor

Most severe, free to view

  • TizanidineM03BX02severe
  • DimenhydrinatA04AB02moderate
  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Diazoxide in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All diazoxide products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Germany · Proglicem
  • France · Proglicem
  • United Kingdom (Northern Ireland) · Eudemine
  • Italy · Proglicem
  • Netherlands · Proglicem

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f418ba98-ac20-4e68-8f5a-b0e923912562
GET /v1/drugs/f418ba98-ac20-4e68-8f5a-b0e923912562?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}

See everything about diazoxide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.